Liafensine

DB14878InvestigationalSmall molecule

Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study).

Mechanism: Pharmacologically active on Sodium-dependent dopamine transporter and Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₂₄H₂₂N₄ · 366.468 g/mol (avg)
Also known as: BMS-820836

Resolves to

Compound

Structure

InChIKeyVCIBGDSRPUOBOG-QFIPXVFZSA-NSMILESCN1C[C@@H](C2=CC3=C(C=CC=C3)C=C2)C2=CC=C(C=C2C1)C1=NN=C(N)C=C1

Targets

What you can answer from here — as of August 29, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Liafensine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.